The real-world Medicare costs of Alzheimer disease: Considerations for policy and care

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Bruce S. Pyenson, Charles Steffens | 28 June 2019

Experts suggest that more than 5 million Americans have Alzheimer disease. It is the most common form of dementia among Medicare beneficiaries. This article compares total Medicare-covered (allowed) costs of patients with Alzheimer disease with the risk-adjusted costs of beneficiaries without dementia over their last years of life, using claims data.

This article was published by the Journal of Managed Care & Specialty Pharmacy.

Read or print the article